Baxter To Spin-Off Vantive (Kidney Care Unit) In July 2024 :

On February 8, 2024, Baxter International Inc. (NYSE: BAX, $39.64, Market Capitalization: $20.1 billion), a global medtech leader, reported steady 4Q23 results, with a...

Related Keywords

United States , China , Australia , Chicago , Illinois , Baxter Centrella , Matt Harbaugh , Chris Toth , Hillrom Progressa , Baxter Sharesource , Iv Solutions , Davita Inc , Baxter International Inc , Biopharma Solutions , A Baxter International Stub , Baxter International , Baxter International Parent , Company Description , Nuvasive Inc , Company Healthcare Systems , Connectivity Solutions , Market Capitalization , Healthcare Systems , Medical Products , Kidney Care , Infusion Therapies , Advanced Surgery , Front Line Care , Online Care , Drug Compounding , Chronic Therapies , Acute Therapies , Welch Allyn Panoptic Plus , Examiner Pro System , Examiner Pro , Launched Spotconnect , Welch Allyn Spot Vision Screener , Vision Screener , Readyconnect System , Launched Floseal , Northwestern Memorial Hospital , Kidney Week , Net Debt , Consolidated Valuation , International Inc , 4q23 , Healthcare Systems And Technologies , Edical Products And Therapies Pharmaceuticals , 4q23 Baxter , Spin Off Research , Spin Off ,